North America Intravenous Immunoglobulin (IVIg) Market by Manufacturers, Countries, Type and Application, Forecast to 2022
- GLO1187504
- 123 Pages
- May 2017
- Healthcare
Scope of the Report:
This report focuses on the Intravenous Immunoglobulin (IVIg) in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Market Segment by Countries, covering
United States
Canada
Mexico
Market Segment by Type, covers
IVIg Liquid
IVIg Powder
Market Segment by Applications, can be divided into
Immunodeficiency
Autoimmune Disease
Acute Infection
There are 15 Chapters to deeply display the North America Intravenous Immunoglobulin (IVIg) market.
Chapter 1, to describe Intravenous Immunoglobulin (IVIg) Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Intravenous Immunoglobulin (IVIg), with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Intravenous Immunoglobulin (IVIg), for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Intravenous Immunoglobulin (IVIg) market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Intravenous Immunoglobulin (IVIg) Research Findings and Conclusion, Appendix, methodology and data source
1 Market Overview
1.1 Intravenous Immunoglobulin (IVIg) Introduction
1.2 Market Analysis by Type
1.2.1 IVIg Liquid
1.2.2 IVIg Powder
1.3 Market Analysis by Applications
1.3.1 Immunodeficiency
1.3.2 Autoimmune Disease
1.3.3 Acute Infection
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Profile
2.1.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Baxter News
2.2 Grifols
2.2.1 Profile
2.2.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Grifols News
2.3 CSL
2.3.1 Profile
2.3.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 CSL News
2.4 Octapharma
2.4.1 Profile
2.4.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Octapharma News
2.5 Biotest
2.5.1 Profile
2.5.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Biotest News
2.6 Kedrion
2.6.1 Profile
2.6.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Kedrion News
2.7 Hualan Bio
2.7.1 Profile
2.7.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Hualan Bio News
2.8 CNBG
2.8.1 Profile
2.8.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 CNBG News
2.9 Shanghai RAAS
2.9.1 Profile
2.9.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Shanghai RAAS News
2.10 CBPO
2.10.1 Profile
2.10.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 CBPO News
2.11 LFB Group
2.11.1 Profile
2.11.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 LFB Group News
2.12 BPL
2.12.1 Profile
2.12.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 BPL News
2.13 Sichuan Yuanda Shuyang
2.13.1 Profile
2.13.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13.4 Business Overview
2.13.5 Sichuan Yuanda Shuyang News
3 North America Intravenous Immunoglobulin (IVIg) Market Competition, by Manufacturer
3.1 North America Intravenous Immunoglobulin (IVIg) Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Intravenous Immunoglobulin (IVIg) Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share
3.4.2 Top 5 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share
3.5 Market Competition Trend
4 North America Intravenous Immunoglobulin (IVIg) Market Analysis by Countries
4.1 North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries
4.2 North America Intravenous Immunoglobulin (IVIg) Sales by Countries (2012-2017)
4.3 North America Intravenous Immunoglobulin (IVIg) Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Intravenous Immunoglobulin (IVIg) by Type
5.1 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type (2012-2017)
5.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2012-2017)
5.2 IVIg Liquid Sales Growth and Price
5.2.1 North America IVIg Liquid Sales Growth (2012-2017)
5.2.2 North America IVIg Liquid Price (2012-2017)
5.3 IVIg Powder Sales Growth and Price
5.3.1 North America IVIg Powder Sales Growth (2012-2017)
5.3.2 North America IVIg Powder Price (2012-2017)
6 North America Market Segmentation Intravenous Immunoglobulin (IVIg) by Application
6.1 North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2012-2017)
6.2 Immunodeficiency Sales Growth (2012-2017)
6.3 Autoimmune Disease Sales Growth (2012-2017)
6.4 Acute Infection Sales Growth (2012-2017)
7 United States Intravenous Immunoglobulin (IVIg) Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Intravenous Immunoglobulin (IVIg) Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
7.3 United States Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)
7.4 United States Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share by Manufacturer
7.4.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Manufacturer
7.5 United States Intravenous Immunoglobulin (IVIg) Export and Import (2012-2017)
8 Canada Intravenous Immunoglobulin (IVIg) Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Intravenous Immunoglobulin (IVIg) Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
8.3 Canada Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)
8.4 Canada Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Intravenous Immunoglobulin (IVIg) Sales and Market Share by Manufacturer
8.4.2 Canada Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Manufacturer
8.5 Canada Intravenous Immunoglobulin (IVIg) Export and Import (2012-2017)
9 Mexico Intravenous Immunoglobulin (IVIg) Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Intravenous Immunoglobulin (IVIg) Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
9.3 Mexico Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)
9.4 Mexico Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Intravenous Immunoglobulin (IVIg) Sales and Market Share by Manufacturer
9.4.2 Mexico Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Manufacturer
9.5 Mexico Intravenous Immunoglobulin (IVIg) Export and Import (2012-2017)
10 Intravenous Immunoglobulin (IVIg) Market Forecast (2017-2022)
10.1 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2017-2022)
10.2 Intravenous Immunoglobulin (IVIg) Market Forecast by Countries (2017-2022)
10.2.1 United States Intravenous Immunoglobulin (IVIg) Forecast (2017-2022)
10.2.2 Canada Intravenous Immunoglobulin (IVIg) Forecast (2017-2022)
10.2.3 Mexico Intravenous Immunoglobulin (IVIg) Forecast (2017-2022)
10.3 Intravenous Immunoglobulin (IVIg) Market Forecast by Type (2017-2022)
10.4 Intravenous Immunoglobulin (IVIg) Market Forecast by Application (2017-2022)
11 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
11.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Intravenous Immunoglobulin (IVIg) Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data SourceList of Tables and Figures
Figure Intravenous Immunoglobulin (IVIg) Picture
Table Product Specifications of Intravenous Immunoglobulin (IVIg)
Figure North America Sales Market Share of Intravenous Immunoglobulin (IVIg) by Types in 2016
Table Types of Intravenous Immunoglobulin (IVIg)
Figure IVIg Liquid Picture
Table Major Manufacturers of IVIg Liquid
Figure IVIg Powder Picture
Table Major Manufacturers of IVIg Powder
Table North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Applications in 2016
Table Applications of Intravenous Immunoglobulin (IVIg)
Figure Immunodeficiency Picture
Figure Autoimmune Disease Picture
Figure Acute Infection Picture
Figure United States Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Table Baxter Basic Information, Manufacturing Base and Competitors
Table Baxter Intravenous Immunoglobulin (IVIg) Type and Applications
Table Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Intravenous Immunoglobulin (IVIg) Type and Applications
Table Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Intravenous Immunoglobulin (IVIg) Type and Applications
Table CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Octapharma Basic Information, Manufacturing Base and Competitors
Table Octapharma Intravenous Immunoglobulin (IVIg) Type and Applications
Table Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biotest Basic Information, Manufacturing Base and Competitors
Table Biotest Intravenous Immunoglobulin (IVIg) Type and Applications
Table Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kedrion Basic Information, Manufacturing Base and Competitors
Table Kedrion Intravenous Immunoglobulin (IVIg) Type and Applications
Table Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hualan Bio Basic Information, Manufacturing Base and Competitors
Table Hualan Bio Intravenous Immunoglobulin (IVIg) Type and Applications
Table Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CNBG Basic Information, Manufacturing Base and Competitors
Table CNBG Intravenous Immunoglobulin (IVIg) Type and Applications
Table CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table Shanghai RAAS Intravenous Immunoglobulin (IVIg) Type and Applications
Table Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CBPO Basic Information, Manufacturing Base and Competitors
Table CBPO Intravenous Immunoglobulin (IVIg) Type and Applications
Table CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table LFB Group Basic Information, Manufacturing Base and Competitors
Table LFB Group Intravenous Immunoglobulin (IVIg) Type and Applications
Table LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BPL Basic Information, Manufacturing Base and Competitors
Table BPL Intravenous Immunoglobulin (IVIg) Type and Applications
Table BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Type and Applications
Table Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2016
Figure North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2017
Table North America Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2016-2017)
Figure North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2016
Figure North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2017
Table North America Intravenous Immunoglobulin (IVIg) Price by Manufacturers (2016-2017)
Figure Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2016
Figure Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2017
Figure Top 5 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2016
Figure Top 5 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2017
Figure North America Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Table North America Intravenous Immunoglobulin (IVIg) Sales by Countries (2012-2017)
Table North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2012-2017)
Figure North America 2012 Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries
Figure North America 2016 Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries
Figure North America Intravenous Immunoglobulin (IVIg) Revenue and Growth (2012-2017)
Table North America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2012-2017)
Table North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2012-2017)
Table North America 2012 Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries
Table North America 2016 Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries
Table North America Intravenous Immunoglobulin (IVIg) Sales by Type (2012-2017)
Table North America Intravenous Immunoglobulin (IVIg) Sales Share by Type (2012-2017)
Table North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2012-2017)
Table North America Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2012-2017)
Figure North America IVIg Liquid Sales Growth (2012-2017)
Figure North America IVIg Liquid Price (2012-2017)
Figure North America IVIg Powder Sales Growth (2012-2017)
Figure North America IVIg Powder Price (2012-2017)
Table North America Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)
Table North America Intravenous Immunoglobulin (IVIg) Sales Share by Application (2012-2017)
Figure North America Immunodeficiency Sales Growth (2012-2017)
Figure North America Autoimmune Disease Sales Growth (2012-2017)
Figure North America Acute Infection Sales Growth (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue and Growth (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales by Type (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2016
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2017
Table United States Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2016-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2016
Figure United States Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2017
Table United States Intravenous Immunoglobulin (IVIg) Export and Import (2012-2017)
Figure Canada Intravenous Immunoglobulin (IVIg) Revenue and Growth (2012-2017)
Figure Canada Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Table Canada Intravenous Immunoglobulin (IVIg) Sales by Type (2012-2017)
Table Canada Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2012-2017)
Table Canada Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)
Table Canada Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2012-2017)
Table Canada Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure Canada Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2016
Figure Canada Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2017
Table Canada Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2016-2017)
Figure Canada Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2016
Figure Canada Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2017
Table Canada Intravenous Immunoglobulin (IVIg) Export and Import (2012-2017)
Figure Mexico Intravenous Immunoglobulin (IVIg) Revenue and Growth (2012-2017)
Figure Mexico Intravenous Immunoglobulin (IVIg) Sales and Growth (2012-2017)
Table Mexico Intravenous Immunoglobulin (IVIg) Sales by Type (2012-2017)
Table Mexico Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2012-2017)
Table Mexico Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)
Table Mexico Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2012-2017)
Table Mexico Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure Mexico Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2016
Figure Mexico Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2017
Table Mexico Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2016-2017)
Figure Mexico Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2016
Figure Mexico Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2017
Table Mexico Intravenous Immunoglobulin (IVIg) Export and Import (2012-2017)
Figure North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2017-2022)
Table North America Intravenous Immunoglobulin (IVIg) Sales Forecast by Countries (2017-2022)
Table North America Intravenous Immunoglobulin (IVIg) Market Share Forecast by Countries (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Forecast (2017-2022)
Figure Canada Intravenous Immunoglobulin (IVIg) Sales Forecast (2017-2022)
Figure Mexico Intravenous Immunoglobulin (IVIg) Sales Forecast (2017-2022)
Table North America Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2017-2022)
Table North America Intravenous Immunoglobulin (IVIg) Market Share Forecast by Type (2017-2022)
Table North America Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2017-2022)
Table North America Intravenous Immunoglobulin (IVIg) Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous Immunoglobulin (IVIg)
Figure Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
Table Raw Materials Sources of Intravenous Immunoglobulin (IVIg) Major Manufacturers in 2016
Table Major Buyers of Intravenous Immunoglobulin (IVIg)
Table Distributors/Traders/ Dealers List
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
